Acetyl-Histone H2B (Lys12) Antibody

What is Acetyl-Histone H2B (Lys12) and why is it important in epigenetic research?

Acetyl-Histone H2B (Lys12), commonly abbreviated as H2BK12ac, is a specific post-translational modification where the lysine residue at position 12 of histone H2B becomes acetylated. This modification plays a critical role in regulating chromatin structure and gene accessibility. Histone acetylation generally promotes a more open chromatin configuration, allowing transcriptional machinery to access DNA and thereby facilitating gene expression . The importance of H2BK12ac in epigenetic research stems from its association with active genes and its role in the complex "histone code" that regulates genomic functions . Researchers studying transcriptional regulation, DNA repair, and cellular differentiation frequently investigate this modification as part of understanding broader epigenetic mechanisms.

How does Acetyl-Histone H2B (Lys12) Antibody differ from other histone modification antibodies?

Acetyl-Histone H2B (Lys12) Antibody is specifically designed to recognize and bind to histone H2B only when acetylated at lysine 12, distinguishing it from antibodies that detect other acetylation sites on H2B (such as K5, K15, or K120) . This high specificity means it does not cross-react with other acetylated histones or even with H2B acetylated at different lysine residues. Unlike antibodies targeting modifications on histone H3 or H4, which might be involved in different regulatory pathways, H2BK12ac antibodies allow researchers to interrogate specific gene regulatory mechanisms associated with this particular modification . The specificity of this antibody enables precise mapping of this modification's distribution across the genome, critical for understanding its functional role in different cellular contexts.

What are the key applications for Acetyl-Histone H2B (Lys12) Antibody in academic research?

Acetyl-Histone H2B (Lys12) Antibody has multiple validated applications in epigenetic research:

These applications enable researchers to investigate the presence, distribution, and dynamics of H2BK12ac in various experimental contexts, from cell cultures to tissue samples across different species .

What are the best practices for using Acetyl-Histone H2B (Lys12) Antibody in Western Blotting experiments?

For optimal results in Western Blotting with Acetyl-Histone H2B (Lys12) Antibody, follow these methodological guidelines:

• Sample preparation: Extract histones using acid extraction methods to efficiently isolate histones from nuclear proteins. Sodium butyrate treatment (a histone deacetylase inhibitor) of cells prior to extraction can enhance acetylation signals .

• Gel electrophoresis: Use 15-18% SDS-PAGE gels to achieve good separation of the low molecular weight histone proteins (approximately 14 kDa) .

• Transfer conditions: Optimize transfer of small proteins by using PVDF membranes and methanol-containing transfer buffer with longer transfer times at lower voltage.

• Blocking and antibody incubation:

  • Blocking: 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

  • Primary antibody: Dilute 1:1000 (range: 1:500-1:5000) in blocking buffer and incubate overnight at 4°C

  • Secondary antibody: Anti-rabbit HRP at 1:2000-1:5000 dilution for 1 hour at room temperature

• Controls: Include both positive controls (sodium butyrate-treated cells) and negative controls (unmodified recombinant H2B) . Additionally, peptide competition assays with acetylated and non-acetylated peptides can confirm specificity.

• Expected results: A single band at approximately 14 kDa should be observed in samples containing acetylated H2B (Lys12) .

Troubleshooting tip: If background is high, increase washing steps with TBST or consider using a more specific blocking agent such as 5% BSA instead of milk.

How should researchers optimize Chromatin Immunoprecipitation (ChIP) protocols when using Acetyl-Histone H2B (Lys12) Antibody?

Optimizing ChIP protocols for Acetyl-Histone H2B (Lys12) Antibody requires careful attention to several critical parameters:

• Cross-linking: For histone modifications, 1% formaldehyde for 10 minutes at room temperature is typically sufficient. Overfixation can mask epitopes and reduce antibody binding efficiency .

• Chromatin shearing: Aim for fragments between 200-500 bp for optimal resolution. Sonication conditions should be empirically determined for each cell type and sonicator model.

• Antibody amount: Use 5-10 μg of antibody per ChIP reaction with 25-30 μg of chromatin input . The optimal antibody-to-chromatin ratio should be determined empirically.

• Immunoprecipitation conditions:

  • Pre-clear chromatin with protein A/G beads to reduce non-specific binding

  • Incubate antibody with chromatin overnight at 4°C with gentle rotation

  • Include appropriate controls: IgG negative control and a positive control antibody (e.g., H3K4me3 for active promoters)

• Washing conditions: Use stringent washing buffers (containing LiCl and NP-40) to minimize background while preserving specific interactions.

• Validation:

  • Perform qPCR on known targets before proceeding to sequencing

  • Use validated primer sets for positive controls (e.g., ACTB/Actb for active genes) and negative controls (gene deserts)

• Enhancement strategies: Consider using spike-in controls for quantitative comparisons between samples, especially in experiments where global levels might change .

The quality of ChIP data can be significantly affected by antibody specificity, so peptide competition assays are recommended to confirm the specificity of the H2BK12ac signal before performing extensive ChIP-seq experiments .

What controls should be included when conducting immunofluorescence experiments with this antibody?

When conducting immunofluorescence experiments with Acetyl-Histone H2B (Lys12) Antibody, the following controls are essential for proper interpretation of results:

• Positive controls:

  • Cells treated with histone deacetylase inhibitors such as Trichostatin A (TSA, 1 μM) for 18 hours, which increases global histone acetylation levels

  • Cell lines known to express high levels of H2BK12ac (e.g., HeLa, C6, and NIH/3T3 cells have been validated)

• Negative controls:

  • Primary antibody omission control (incubation with antibody diluent only)

  • Isotype control (using matched concentration of non-specific rabbit IgG)

  • Peptide competition control (pre-incubating antibody with acetylated H2BK12 peptide)

• Technical controls:

  • DAPI or Hoechst counterstaining to confirm nuclear localization

  • Co-staining with general H2B antibody to normalize acetylation signal to total H2B levels

  • Sample processing controls (fixed and permeabilized identical samples with different antibodies)

• Cell treatment validation:

  • HDAC inhibitors (TSA, sodium butyrate) should increase signal intensity

  • HDAC overexpression should decrease signal intensity

  • Comparing quiescent vs. proliferating cells (acetylation levels often differ)

The immunofluorescence protocol typically involves formaldehyde fixation (4%, 10 minutes), permeabilization with 0.1-0.5% Triton X-100, blocking with 5% normal goat serum and 1% BSA, and antibody dilution of 1:100-1:500 . Nuclear localization of H2BK12ac signal should be verified by co-localization with DAPI staining, showing a punctate nuclear pattern that excludes nucleoli .

How can Acetyl-Histone H2B (Lys12) Antibody be used to study the relationship between histone modifications and gene expression?

Combining Acetyl-Histone H2B (Lys12) Antibody with other methodologies can provide comprehensive insights into the relationship between this modification and gene expression:

• ChIP-seq integration with transcriptomics:

  • Perform ChIP-seq with H2BK12ac antibody and RNA-seq on the same cell population

  • Correlate H2BK12ac peak intensity at promoters and gene bodies with transcript levels

  • Compare H2BK12ac distribution in actively transcribed vs. silent genes

• Sequential ChIP (Re-ChIP):

  • Use H2BK12ac antibody in combination with antibodies against other histone modifications (e.g., H3K4me3, H3K27ac) or transcription factors

  • This approach determines co-occurrence of multiple regulatory marks at the same genomic loci

• CUT&RUN or CUT&Tag approaches:

  • These techniques provide higher resolution and lower background than traditional ChIP

  • Particularly useful for studying H2BK12ac in limited cell numbers or rare cell populations

• Genome editing to study causality:

  • CRISPR-Cas9 mediated knockout of specific histone acetyltransferases (HATs) or deacetylases (HDACs)

  • Follow changes in H2BK12ac levels and correlate with alterations in gene expression

  • Introduction of H2B mutations (K12R) to prevent acetylation at this specific site

• Single-cell approaches:

  • Combine immunofluorescence for H2BK12ac with single-cell RNA-seq

  • Investigate cell-to-cell variability in H2BK12ac levels and its correlation with gene expression heterogeneity

Research has shown that H2BK12ac is typically enriched at actively transcribed genes, particularly at promoters and the 5' regions of gene bodies . The modification often co-occurs with other active marks like H3K4me3 and H3K27ac, forming part of the combinatorial histone code that regulates gene expression . Changes in H2BK12ac levels in response to cellular signaling or environmental stimuli can be quantified and correlated with dynamic changes in gene expression programs.

Acetyl-Histone H2B (Lys12) exhibits distinct patterns and functions across different cell types and disease contexts:

Normal Cellular Contexts:

• Embryonic Development and Stem Cells:

  • H2BK12ac levels change during cellular differentiation

  • Often co-regulated with other developmentally important histone modifications

  • Involved in maintaining stem cell pluripotency networks and lineage-specific gene activation

• Tissue-Specific Patterns:

  • Immunohistochemistry studies show varied H2BK12ac patterns across tissues:

    • Human colon tissue shows distinct nuclear staining patterns

    • Rat ovary and mouse testis display cell type-specific distributions

    • Neural cells (C6) show different patterns compared to epithelial cells (HeLa)

• Cell Cycle Regulation:

  • Dynamic changes in H2BK12ac occur during cell cycle progression

  • May be involved in replication-coupled chromatin assembly

  • Coordinates with DNA replication timing and chromosome condensation

Disease Contexts:

• Cancer:

  • Altered H2BK12ac patterns observed in multiple cancer types

  • Changes in HAT/HDAC expression that regulate H2BK12ac are associated with cancer progression

  • Potential biomarker for cancer stratification or prognosis

• Neurodegenerative Disorders:

  • Dysregulation of histone acetylation, including H2BK12ac, linked to neurodegenerative diseases

  • HDAC inhibitors that affect H2BK12ac levels show neuroprotective effects in some models

• Inflammatory Conditions:

  • H2BK12ac may regulate inflammatory gene expression programs

  • Dynamic changes occur during immune cell activation and cytokine responses

Methodological approaches to study context-specific functions:

• Single-cell epigenomic profiling to capture cell type heterogeneity

• Tissue-specific conditional knockout models of relevant HATs/HDACs

• Patient-derived samples to compare normal vs. disease states

• Pharmacological modulation of H2BK12ac using HDAC inhibitors or HAT activators

• Integration of H2BK12ac ChIP-seq data with tissue-specific transcriptomes and proteomes

Understanding the context-specific roles of H2BK12ac can provide insights into both normal biological processes and disease mechanisms, potentially identifying novel therapeutic approaches targeting epigenetic regulators.

What are common challenges when using Acetyl-Histone H2B (Lys12) Antibody and how can they be resolved?

Researchers may encounter several challenges when working with Acetyl-Histone H2B (Lys12) Antibody across different applications. Here are common issues and their solutions:

Western Blotting Challenges:

ChIP Challenges:

Immunofluorescence Challenges:

General Technical Recommendations:

• Antibody validation: Always validate new antibody lots using peptide arrays or dot blots with acetylated and non-acetylated peptides .

• Sample preparation: For consistent results, standardize histone extraction protocols and use fresh samples when possible.

• Controls: Include technical controls (antibody omission, isotype controls) and biological controls (HDAC inhibitor treatment, HAT knockdown) .

• Storage conditions: Store antibody according to manufacturer recommendations (typically -20°C or -80°C) and avoid repeated freeze-thaw cycles .

• Cross-antibody validation: When possible, validate key findings with a second H2BK12ac antibody from a different manufacturer to ensure reproducibility .

How can researchers ensure specificity when using Acetyl-Histone H2B (Lys12) Antibody?

Ensuring antibody specificity is critical for reliable experimental results. For Acetyl-Histone H2B (Lys12) Antibody, consider the following comprehensive validation approaches:

1. Peptide Competition Assays:

• Pre-incubate the antibody with excess acetylated H2BK12 peptide (positive competition)

• Pre-incubate with unmodified H2B peptide or peptides acetylated at other lysine residues (negative competition)

• A specific antibody will show signal elimination only with the acetylated H2BK12 peptide

2. Peptide Array or Dot Blot Validation:

• Test antibody against a panel of modified and unmodified histone peptides

• Include H2B peptides with acetylation at various lysine residues (K5, K12, K15, K20)

• Quantify signal intensity to determine cross-reactivity

• Results should show strong signal only for H2BK12ac peptide

3. Genetic/Pharmacological Interventions:

• HDAC inhibitor treatment (TSA, sodium butyrate) should increase signal

• HAT inhibitors or knockdown of relevant HATs should decrease signal

• H2B K12R mutant (preventing acetylation) should show no signal

4. Multiple Antibody Validation:

• Compare results using H2BK12ac antibodies from different vendors or different clones

• Consistent results across antibodies increase confidence in specificity

5. Mass Spectrometry Correlation:

• Perform IP with the antibody followed by mass spectrometry

• Confirm enrichment of H2BK12ac peptide over other modified peptides

6. Application-Specific Controls:

For ChIP experiments:

• Include IgG control and input samples

• Test known genomic regions that should be negative for H2BK12ac

• Compare with ChIP-seq datasets generated with other validated H2BK12ac antibodies

For Western blotting:

• Use recombinant H2B (unmodified) as a negative control

• Compare with other histone protein bands (H2A, H3, H4) to confirm specificity

For immunostaining:

• Perform staining on cell types with knockdown of relevant HATs

• Confirm nuclear localization with counterstains

• Test antibody on fixed tissues with known H2BK12ac patterns

Data from multiple validation approaches should be integrated to provide comprehensive evidence of antibody specificity before proceeding with extensive experiments. Documentation of these validation steps strengthens the reliability of research findings.

What are the recent advances in understanding the biological significance of H2BK12 acetylation?

Recent research has expanded our understanding of H2BK12 acetylation's biological significance across multiple domains:

Transcriptional Regulation:

• H2BK12ac has been identified as part of a specific promoter signature associated with actively transcribed genes

• Studies show that H2BK12ac often co-occurs with H2BK5ac and H2BK15ac at promoters of highly expressed genes

• Dynamic changes in H2BK12ac levels correlate with transcriptional responses to environmental stimuli and stress conditions

Chromatin Structure and Organization:

• H2BK12ac contributes to nucleosome stability and dynamics

• This modification influences higher-order chromatin structure by altering internucleosomal interactions

• Increasing evidence suggests H2BK12ac works cooperatively with other histone modifications to maintain open chromatin regions

Cell Differentiation and Development:

• Genome-wide mapping studies have revealed that H2BK12ac patterns change significantly during cellular differentiation

• The modification plays roles in maintaining stem cell pluripotency networks and in activating lineage-specific genes during development

• Developmental timing of H2BK12ac changes appears to be tightly regulated in embryonic tissues

Disease Associations:

• Altered H2BK12ac patterns have been observed in various cancers, correlating with changes in gene expression profiles

• Neurodegenerative disorders show disruptions in H2BK12ac distribution across neuronal genomes

• Inflammatory conditions exhibit dynamic regulation of H2BK12ac at immune response genes

Cross-talk with Other Epigenetic Mechanisms:

• Recent studies have uncovered functional interactions between H2BK12ac and DNA methylation patterns

• H2BK12ac levels influence recruitment of chromatin remodeling complexes

• Evidence suggests bidirectional regulation between H2BK12ac and non-coding RNAs

These advances have been facilitated by improvements in technologies for detection and mapping of histone modifications, including high-resolution ChIP-seq, CUT&RUN/CUT&Tag approaches, and single-cell epigenomic profiling methods.

How does Acetyl-Histone H2B (Lys12) antibody contribute to multi-omics research approaches?

Acetyl-Histone H2B (Lys12) antibody serves as a powerful tool for integrating epigenetic data into multi-omics research frameworks:

1. Integration with Transcriptomics:

• ChIP-seq with H2BK12ac antibody combined with RNA-seq enables correlation between this specific acetylation mark and gene expression levels

• Helps identify genes where H2BK12ac plays a regulatory role vs. genes where it may be a consequence of transcription

• Time-course experiments can reveal temporal relationships between H2BK12ac changes and transcriptional responses

2. Proteomics Integration:

• Antibody-based pulldowns followed by mass spectrometry identify protein complexes associated with H2BK12ac regions

• Reveals reader proteins that specifically recognize this modification

• Helps construct protein interaction networks around H2BK12ac-marked chromatin

3. Chromatin Accessibility Analysis:

• Combining H2BK12ac ChIP-seq with ATAC-seq or DNase-seq reveals relationships between this modification and chromatin accessibility

• Helps distinguish active enhancers from active promoters based on histone modification patterns

• Provides insights into the mechanistic basis of chromatin state transitions

4. 3D Genome Organization:

• Integration with Hi-C or ChIA-PET data connects H2BK12ac patterns with higher-order chromatin organization

• Reveals how H2BK12ac-marked regions interact in 3D nuclear space

• Identifies potential regulatory interactions between distant genomic elements

5. Single-Cell Multi-omics:

• Recent advances in single-cell technologies allow integration of H2BK12ac data with other omics layers at single-cell resolution

• Reveals cell-to-cell heterogeneity in H2BK12ac patterns and how this correlates with transcriptional heterogeneity

• Helps identify cell states and transitions during development or disease progression

Methodological Approaches:

• Sequential ChIP-seq for H2BK12ac followed by other histone marks

• Cut&Run or Cut&Tag with H2BK12ac antibody for higher resolution profiling

• CoBRA (Co-Binding Region Analysis) to identify transcription factors co-occurring with H2BK12ac

• Integrative computational frameworks that analyze H2BK12ac patterns alongside multiple omics datasets

These multi-omics approaches provide comprehensive understanding of how H2BK12 acetylation fits within the broader context of cellular regulation, moving beyond correlative observations to mechanistic insights about epigenetic regulation.

What emerging technologies are enhancing the study of histone modifications like H2BK12ac?

Several cutting-edge technologies are transforming how researchers study histone modifications like H2BK12ac, offering improved sensitivity, specificity, and resolution:

1. Advanced Antibody-Based Technologies:

• CUT&RUN (Cleavage Under Targets & Release Using Nuclease): Uses antibody-directed nuclease activity to cleave DNA specifically at H2BK12ac sites, providing higher signal-to-noise ratio than traditional ChIP

• CUT&Tag (Cleavage Under Targets & Tagmentation): Combines antibody targeting with Tn5 transposase tagmentation, allowing simultaneous DNA fragmentation and adapter addition at H2BK12ac sites

• ULI-NChIP (Ultra-Low-Input Native ChIP): Enables H2BK12ac profiling from as few as 1,000 cells, critical for rare cell populations or clinical samples

2. Mass Spectrometry Innovations:

• Middle-down MS: Analyzes larger histone fragments to preserve information about co-occurring modifications alongside H2BK12ac

• Targeted MS approaches: Uses parallel reaction monitoring to quantify H2BK12ac with high sensitivity

• Crosslinking MS: Identifies proteins that specifically interact with H2BK12ac-modified nucleosomes

3. CRISPR-Based Epigenome Editing:

• Engineered dCas9 fused to histone acetyltransferases for site-specific writing of H2BK12ac

• CRISPR screens targeting writers/erasers/readers of H2BK12ac to identify functional consequences

• CRISPR-based imaging of H2BK12ac distribution in living cells using acetylation-specific reader domains

4. Single-Cell and Spatial Technologies:

• Single-cell ChIP-seq adaptations for H2BK12ac profiling in individual cells

• CUT&Tag-pro approaches for simultaneous profiling of H2BK12ac and protein levels

• Spatial epigenomics methods to map H2BK12ac distribution within tissue contexts

5. Computational and AI Approaches:

• Deep learning algorithms for predicting H2BK12ac sites from DNA sequence and chromatin features

• Network analysis tools to identify H2BK12ac-associated regulatory circuits

• Integrative modeling of histone modification dynamics, including H2BK12ac turnover rates

6. Synthetic Biology Approaches:

• Engineered histone sensors that report on H2BK12ac status in living cells

• Reconstituted chromatin systems with defined H2BK12ac patterns for mechanistic studies

• Orthogonal chemical biology approaches to introduce H2BK12ac with temporal precision

These technological advances are enabling researchers to move beyond descriptive studies of H2BK12ac patterns toward a mechanistic understanding of how this modification influences chromatin function and gene regulation. By combining multiple advanced technologies, researchers can build comprehensive models of H2BK12ac dynamics and function in various biological contexts.

What are the key considerations for designing experiments involving Acetyl-Histone H2B (Lys12) Antibody?

When designing experiments with Acetyl-Histone H2B (Lys12) Antibody, researchers should consider these critical factors for robust and interpretable results:

Experimental Planning:

• Biological question specificity: Clearly define whether you're investigating H2BK12ac distribution, dynamics, or functional consequences

• Appropriate cell/tissue systems: Select models where H2BK12ac has been documented or is likely to play a role

• Temporal considerations: For dynamic processes, include multiple timepoints to capture H2BK12ac changes

• Relevant treatments: Consider HDAC inhibitors as positive controls and HAT inhibitors as negative controls

Technical Considerations:

• Antibody validation: Validate each new lot of antibody using peptide arrays or dot blots with acetylated and non-acetylated peptides

• Application-specific optimization:

  • For ChIP: Optimize chromatin preparation, antibody amount, and washing conditions

  • For Western blotting: Ensure proper extraction of histones and optimal transfer conditions

  • For immunofluorescence: Optimize fixation, permeabilization, and antigen retrieval

• Controls implementation:

  • Include technical controls (IgG, no-antibody, isotype controls)

  • Include biological controls (treated/untreated samples, acetylation-deficient mutants)

Data Analysis:

• Quantification methods: Use appropriate normalization strategies (e.g., normalization to total H2B for Western blots)

• Statistical analysis: Apply appropriate statistical tests based on experimental design and data distribution

• Multi-omics integration: Consider how H2BK12ac data will be integrated with other datasets (transcriptomics, other histone modifications)

Practical Recommendations:

• Start with established protocols and cell types where H2BK12ac has been studied (HeLa, C6, NIH/3T3)

• Include treatments that are known to affect global acetylation (TSA, sodium butyrate) as controls

• Consider collaborations with epigenetics specialists for complex experimental designs

• Maintain consistent experimental conditions across replicates to reduce technical variability

• Document all validation steps to strengthen publication quality

By carefully considering these factors during experimental design, researchers can generate high-quality, reproducible data on H2BK12ac that advances understanding of its biological roles.

How can researchers effectively interpret and report Acetyl-Histone H2B (Lys12) Antibody data in publications?

Effective interpretation and reporting of Acetyl-Histone H2B (Lys12) Antibody data is crucial for publication quality and reproducibility. Consider these comprehensive guidelines:

Data Presentation:

• Western Blot Images:

  • Show full blots with molecular weight markers

  • Include control proteins (total H2B, other histones)

  • Present quantification of multiple biological replicates with appropriate statistical analysis

  • Clearly indicate antibody dilution, exposure times, and image processing methods

• ChIP and ChIP-seq Data:

  • Present both genome browser tracks and aggregate plots (e.g., around TSS)

  • Include known positive and negative regions as controls

  • Show enrichment over input and IgG controls

  • Provide quality metrics (peak numbers, FRiP scores, replicate correlations)

• Immunofluorescence Images:

  • Include separate channels and merged images

  • Show consistent scale bars and magnification across comparable images

  • Present representative images alongside quantification from multiple fields/samples

  • Include positive controls (HDAC inhibitor treated) and negative controls

Methodological Reporting:

Provide detailed methods sections including:

• Antibody Information:

  • Vendor, catalog number, lot number, RRID

  • Validation methods performed

  • Dilutions used for each application

  • Storage and handling conditions

• Protocol Details:

  • Complete ChIP protocols (fixation time, sonication conditions, wash buffers)

  • Western blot conditions (extraction method, gel percentage, transfer conditions)

  • Immunofluorescence procedures (fixation, permeabilization, mounting)

• Data Analysis:

  • Software packages and versions used

  • Analysis parameters and thresholds

  • Statistical methods with justification

  • Data normalization approaches

Interpretation Guidelines:

• Contextualize Within Histone Code:

  • Discuss H2BK12ac in relation to other histone modifications

  • Address potential cross-talk between modifications

  • Consider the broader chromatin landscape

• Functional Interpretation:

  • Connect H2BK12ac patterns to functional outcomes (gene expression, chromatin accessibility)

  • Distinguish correlation from causation

  • Consider cell type specificity and biological context

• Limitations Acknowledgment:

  • Discuss potential antibody cross-reactivity issues

  • Address technical limitations of the approaches used

  • Acknowledge alternative interpretations of the data

• Consistency With Literature:

  • Compare findings with previous H2BK12ac studies

  • Address any discrepancies with published results

  • Place findings in the broader context of histone acetylation research